Immunai
ID: 7400439Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
4
Funding Rounds
$313.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Sa****** | - | - | - |
| Da* Li***** | - | - | - |
| Lu** Vo**** |
|
- | |
| No** So***** |
|
- | |
| Da*** We*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Immunai has raised a total of $253m in funding over 4 rounds.
Key Insights:
- Immunai September 2024 Venture - Series Unknown Funding Round: $18m
- Immunai Series B round, October 2021: $215m
- Immunai Seed round, May 2020: $20m
- Immunai Series A round February 2021: $60m
Industries
Immunai is active in the following industries: